Aimmune Therapeutics Inc AIMT:NASDAQ

Last Price$15.86NASDAQ Closing Price as of 4:00PM ET 4/08/20
NASDAQ 15-minute delayed Bid/Ask Quotes
Today's Change+1.05(7.09%)
Bid (Size)$15.80 (10)
Ask (Size)$16.02 (9)
Day Low / High$14.87 - 16.42
Volume1.5 M
  • Latest Stories
  • Commentary and Analysis
Insider Trends: Insider Buying Extended with Purchase of AIMSI Technologies Stock
5:05PM ET 3/19/2020 MT Newswires

Patrick G Enright, Director, made a purchase of 125,000 shares in AIMSI Technologies (AIMT) on Mar 17, 2020, for $1,420,045. After the Form 4 filing with...

Insider Trends: Insider Purchase Adds to Aimmune Therapeutics Positive Trend
5:05PM ET 3/19/2020 MT Newswires

Patrick G Enright, Director, on Mar 17, 2020, executed a purchase for 125,000 shares in Aimmune Therapeutics (AIMT) for $1,420,045. Enright has control...

--Analyst Actions: JMP Securities Downgrades Aimmune Therapeutics to Market Perform From Market Outperform
9:52AM ET 3/18/2020 MT Newswires

Price: 11.09, Change: -0.42, Percent Change: -3.65 ...

Aimmune Therapeutics Says First Patients in US Being Treated With Peanut Allergy Drug Palforzia
11:18AM ET 3/16/2020 MT Newswires

Aimmune Therapeutics (AIMT) announced Monday the first US patients being treated with Palforzia for peanut allergy. The drug, which was approved by the US...

--Analyst Actions: Wedbush Reduces Price Target on Aimmune Therapeutics to $66 From $74, Maintains Outperform Rating
6:37AM ET 3/04/2020 MT Newswires

Price: 22.92, Change: -0.91, Percent Change: -3.82 ...

--Analyst Actions: Stifel Nicolaus Cuts Aimmune Therapeutics Price Target to $32 From $34, Maintains Hold Rating
11:56AM ET 3/02/2020 MT Newswires

Price: 23.57, Change: -0.24, Percent Change: -1.01 ...

--Analyst Actions: Credit Suisse Cuts Aimmune Therapeutics' Price Target to $29 From $34 on Slower Palforzia Launch, Maintains Neutral Rating
11:03AM ET 3/02/2020 MT Newswires

Price: 23.33, Change: -0.48, Percent Change: -2.02 ...

MT Newswires After-Hours News Movers
5:55PM ET 2/27/2020 MT Newswires

Some of the stocks moving on news-driven events in Thursday's after-hours include: FTSV, +23.18% SCOR, +20.20% MDCA, +19.11% FTCH, +14.62% AMC, +9.52%...

Aimmune Therapeutics Q4 Loss Per Share in Line With Consensus
5:28PM ET 2/27/2020 MT Newswires

Aimmune Therapeutics (AIMT) on Thursday reported Q4 loss per share of $1.06, widening from $0.95 a year ago. The result was in line with the consensus...

--Analyst Actions: Wedbush Cuts Price Target on Aimmune Therapeutics to $74 From $81, Maintains Outperform Rating
6:33AM ET 2/06/2020 MT Newswires

Price: 30.28, Change: +0.91, Percent Change: +3.10 ...